|
|
||||||||
Papers In Press, published online ahead of print December 16, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ICOS Corp., Bothell, WA 98021
Corresponding Author: psnyder{at}icos.com
This study assessed the effects of selective inhibitors of 3',5'-cyclic nucleotide phosphodiesterases (PDEs) on adipocyte lipolysis. IC224, a selective inhibitor of type 1 phosphodiesterase (PDE1), suppressed lipolysis in murine 3T3-L1 adipocytes (69.6 +/- 5.4% of vehicle control) but had no effect in human adipocytes. IC933, a selective inhibitor of type 2 phosphodiesterase (PDE2), had no effect on lipolysis in either cultured murine 3T3-L1 adipocytes or human adipocytes. Inhibition of type 3 phosphodiesterase (PDE3) with cilostamide moderately stimulated lipolysis in murine 3T3-L1 and rat adipocytes (397 +/- 25% and 235 +/- 26% of control, respectively) and markedly stimulated lipolysis in human adipocytes (932 +/- 7.6% of control). Inhibition of type 4 phosphodiesterase (PDE4) with rolipram moderately stimulated lipolysis in murine 3T3-L1 adipocytes (291 +/- 13% of control) and weakly stimulated lipolysis in rat adipocytes (149 +/- 7.0% of control), but had no effect on lipolysis in human adipocytes. Cultured adipocytes also responded differently to a combination of PDE3 and PDE4 inhibitors. Simultaneous exposure to cilostamide and rolipram had a synergistic effect on lipolysis in murine 3T3-L1 and rat adipocytes, but not in human adipocytes. Hence, the relative importance of PDE3 and PDE4 in regulating lipolysis differed in cultured murine, rat, and human adipocytes.
Revised on November 29, 2004
Accepted on December 7, 2004
The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Wang and N. K. Edens mRNA expression and antilipolytic role of phosphodiesterase 4 in rat adipocytes in vitro J. Lipid Res., May 1, 2007; 48(5): 1099 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Peluso Flavonoids Attenuate Cardiovascular Disease, Inhibit Phosphodiesterase, and Modulate Lipid Homeostasis in Adipose Tissue and Liver Experimental Biology and Medicine, September 1, 2006; 231(8): 1287 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Bender and J. A. Beavo Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use Pharmacol. Rev., September 1, 2006; 58(3): 488 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kang and L. E. Nagy Chronic Ethanol Feeding Suppresses {beta}-Adrenergic Receptor-Stimulated Lipolysis in Adipocytes Isolated from Epididymal Fat Endocrinology, September 1, 2006; 147(9): 4330 - 4338. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |